Integrated-gut-liver-on-a-chip platform as an in vitro human model of non-alcoholic fatty liver disease.


Journal

Communications biology
ISSN: 2399-3642
Titre abrégé: Commun Biol
Pays: England
ID NLM: 101719179

Informations de publication

Date de publication:
23 03 2023
Historique:
received: 25 06 2020
accepted: 14 03 2023
entrez: 24 3 2023
pubmed: 25 3 2023
medline: 28 3 2023
Statut: epublish

Résumé

Non-alcoholic fatty liver disease (NAFLD) afflicts a significant percentage of the population; however, no effective treatments have yet been established because of the unsuitability of in vitro assays and animal experimental models. Here, we present an integrated-gut-liver-on-a-chip (iGLC) platform as an in vitro human model of the gut-liver axis (GLA) by co-culturing human gut and liver cell lines interconnected via microfluidics in a closed circulation loop, for the initiation and progression of NAFLD by treatment with free fatty acids (FFAs) for 1 and 7 days, respectively. Co-cultured Caco-2 gut-mimicking cells and HepG2 hepatocyte-like cells demonstrate the protective effects from apoptosis against FFAs treatment, whereas mono-cultured cells exhibit induced apoptosis. Phenotype and gene expression analyses reveal that the FFAs-treated gut and liver cells accumulated intracellular lipid droplets and show an increase in gene expression associated with a cellular response to copper ions and endoplasmic reticulum stress. As an in vitro human GLA model, the iGLC platform may serve as an alternative to animal experiments for investigating the mechanisms of NAFLD.

Identifiants

pubmed: 36959276
doi: 10.1038/s42003-023-04710-8
pii: 10.1038/s42003-023-04710-8
pmc: PMC10036655
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

310

Informations de copyright

© 2023. The Author(s).

Références

J Gastroenterol. 2018 Mar;53(3):362-376
pubmed: 29247356
Integr Biol (Camb). 2015 Apr;7(4):383-91
pubmed: 25739725
Sci Rep. 2018 Jul 27;8(1):11365
pubmed: 30054551
J Lipid Res. 2016 Oct;57(10):1758-1770
pubmed: 27049024
Lab Chip. 2005 Oct;5(10):1005-7
pubmed: 16175253
Microfluid Nanofluidics. 2009 Sep 1;7(3):291-306
pubmed: 20357909
J Biol Inorg Chem. 2018 Dec;23(8):1331-1349
pubmed: 30302601
Biotechnol Bioeng. 2018 Nov;115(11):2817-2827
pubmed: 29981260
Lab Chip. 2009 Feb 21;9(4):555-63
pubmed: 19190791
J Hepatol. 2019 Mar;70(3):531-544
pubmed: 30414863
Lab Chip. 2020 Apr 21;20(8):1410-1417
pubmed: 32202263
Biochim Biophys Acta. 2012 Sep;1821(9):1211-23
pubmed: 22691950
Chem Biol Interact. 2007 Jan 30;165(2):106-16
pubmed: 17188672
Front Bioeng Biotechnol. 2020 Mar 17;8:163
pubmed: 32258006
Science. 1998 Nov 6;282(5391):1145-7
pubmed: 9804556
Biotechnol Prog. 2021 May;37(3):e3121
pubmed: 33393209
ALTEX. 2017;34(2):301-310
pubmed: 27846345
Gut. 2017 Jan;66(1):180-190
pubmed: 27646933
Metabolism. 2015 Sep;64(9):982-90
pubmed: 26024755
Genome Biol. 2014;15(12):550
pubmed: 25516281
Biochem Biophys Res Commun. 2017 Jan 8;482(2):323-328
pubmed: 27856254
Front Bioeng Biotechnol. 2019 Jun 18;7:144
pubmed: 31275931
Commun Biol. 2021 Sep 15;4(1):1080
pubmed: 34526653
Lab Chip. 2020 Apr 14;20(8):1472-1492
pubmed: 32211684
Lab Chip. 2012 Apr 7;12(7):1224-37
pubmed: 22318426
Biometals. 2018 Aug;31(4):505-515
pubmed: 29623473
Nucleic Acids Res. 2017 Jul 3;45(W1):W130-W137
pubmed: 28472511
Biomicrofluidics. 2022 Aug 26;16(4):044113
pubmed: 36039115
Hepatology. 2018 Jan;67(1):328-357
pubmed: 28714183
Integr Biol (Camb). 2013 Sep;5(9):1130-40
pubmed: 23817533
Front Pharmacol. 2020 Sep 04;11:529976
pubmed: 33013380
Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):2883-8
pubmed: 18287077
ACS Biomater Sci Eng. 2021 Jul 12;7(7):2880-2899
pubmed: 34275293
Horm Mol Biol Clin Investig. 2018 Aug 11;41(1):
pubmed: 30098284
J Hepatol. 2015 Apr;62(1 Suppl):S47-64
pubmed: 25920090
Nat Rev Gastroenterol Hepatol. 2016 Jul;13(7):412-25
pubmed: 27273168
Metabolism. 2016 Aug;65(8):1038-48
pubmed: 26823198
World J Gastroenterol. 2016 Sep 28;22(36):8078-93
pubmed: 27688650
J Hepatol. 2020 Mar;72(3):558-577
pubmed: 31622696
PLoS Biol. 2018 Jul 3;16(7):e2005970
pubmed: 29969450
Lab Chip. 2012 Jun 21;12(12):2165-74
pubmed: 22434367
Lab Chip. 2009 Aug 7;9(15):2132-9
pubmed: 19606288
Cell Stem Cell. 2018 Mar 1;22(3):310-324
pubmed: 29499151
BMC Bioinformatics. 2011 Aug 04;12:323
pubmed: 21816040
Assay Drug Dev Technol. 2014 Nov-Dec;12(9-10):536-47
pubmed: 25506803
Hepatol Commun. 2019 Mar 01;3(4):456-470
pubmed: 30976737
Sci Rep. 2022 Aug 17;12(1):13988
pubmed: 35977967
PLoS One. 2011;6(12):e28338
pubmed: 22162763
Front Bioeng Biotechnol. 2020 Sep 08;8:568092
pubmed: 33015019
iScience. 2021 Dec 04;25(1):103549
pubmed: 34977507
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
pubmed: 16199517
Nat Methods. 2012 Mar 04;9(4):357-9
pubmed: 22388286
Nat Rev Microbiol. 2020 Feb;18(2):67-83
pubmed: 31857715
PLoS One. 2017 Feb 1;12(2):e0169412
pubmed: 28146569
Lab Chip. 2017 Feb 28;17(5):782-794
pubmed: 28112323
Adv Healthc Mater. 2013 Feb;2(2):287-91
pubmed: 23184815
RSC Adv. 2018 Sep 19;8(57):32440-32453
pubmed: 35547722
Gut. 2016 Feb;65(2):330-9
pubmed: 26338727
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
J Hepatol. 2018 Feb;68(2):280-295
pubmed: 29154964
Biochem Biophys Res Commun. 1999 Aug 2;261(2):225-32
pubmed: 10425169
Int J Pharm. 2022 Nov 5;627:122253
pubmed: 36183916
Toxicol In Vitro. 2020 Jun;65:104815
pubmed: 32119998
Hepatology. 2018 Jan;67(1):123-133
pubmed: 28802062
Biomaterials. 2019 Dec;225:119521
pubmed: 31600674
J Hepatol. 2017 Nov;67(5):1084-1103
pubmed: 28526488
Database (Oxford). 2018 Jan 1;2018:
pubmed: 30576484
Cell. 2007 Nov 30;131(5):861-72
pubmed: 18035408
Antioxidants (Basel). 2020 May 13;9(5):
pubmed: 32414055
Mol Biol Cell. 2000 Dec;11(12):4347-58
pubmed: 11102528
Nat Med. 2018 Jul;24(7):908-922
pubmed: 29967350
AAPS J. 2017 Sep;19(5):1499-1512
pubmed: 28752430
Biomed Microdevices. 2009 Jun;11(3):547-55
pubmed: 19130244
Science. 2010 Jun 25;328(5986):1662-8
pubmed: 20576885
Biotechnol Bioeng. 2017 Nov;114(11):2648-2659
pubmed: 28667746
Commun Biol. 2020 Nov 13;3(1):674
pubmed: 33188302
Hepatol Int. 2020 Jul;14(4):463-474
pubmed: 32578019
Science. 2007 Dec 21;318(5858):1917-20
pubmed: 18029452
Bioorg Chem. 2020 Jun;99:103818
pubmed: 32276135
Genome Biol. 2006;7(10):R100
pubmed: 17076895
AIChE J. 2018 Dec;64(12):4351-4360
pubmed: 31402795
Int J Biol Sci. 2018 Jul 27;14(10):1277-1290
pubmed: 30123076

Auteurs

Jiandong Yang (J)

Department of Micro Engineering, Kyoto University, Kyotodaigaku-Katsura, Nishikyo-ku, Kyoto, 615-8540, Japan.

Yoshikazu Hirai (Y)

Department of Micro Engineering, Kyoto University, Kyotodaigaku-Katsura, Nishikyo-ku, Kyoto, 615-8540, Japan. hirai@me.kyoto-u.ac.jp.
Department of Mechanical Engineering and Science, Kyoto University, Kyotodaigaku-Katsura, Nishikyo-ku, Kyoto, 615-8540, Japan. hirai@me.kyoto-u.ac.jp.

Kei Iida (K)

Medical Research Support Center, Graduate School of Medicine, Kyoto University, Yoshida Konoe-cho, Kyoto, 606-8501, Japan.
Faculty of Science and Engineering, Kindai University, 3-4-1 Kowakae, Higashiosaka, Osaka, 577-8502, Japan.

Shinji Ito (S)

Faculty of Science and Engineering, Kindai University, 3-4-1 Kowakae, Higashiosaka, Osaka, 577-8502, Japan.

Marika Trumm (M)

Department of Micro Engineering, Kyoto University, Kyotodaigaku-Katsura, Nishikyo-ku, Kyoto, 615-8540, Japan.
Institute for Integrated Cell-Material Sciences, Kyoto University, Yoshida-Ushinomiya-cho, Sakyo-ku, Kyoto, 606-8501, Japan.
Institute for Pharmacy and Molecular Biotechnology, Heidelberg University, Heidelberg, 69120, Germany.

Shiho Terada (S)

Institute for Integrated Cell-Material Sciences, Kyoto University, Yoshida-Ushinomiya-cho, Sakyo-ku, Kyoto, 606-8501, Japan.

Risako Sakai (R)

Institute for Integrated Cell-Material Sciences, Kyoto University, Yoshida-Ushinomiya-cho, Sakyo-ku, Kyoto, 606-8501, Japan.

Toshiyuki Tsuchiya (T)

Department of Micro Engineering, Kyoto University, Kyotodaigaku-Katsura, Nishikyo-ku, Kyoto, 615-8540, Japan.

Osamu Tabata (O)

Department of Micro Engineering, Kyoto University, Kyotodaigaku-Katsura, Nishikyo-ku, Kyoto, 615-8540, Japan.
Institute for Integrated Cell-Material Sciences, Kyoto University, Yoshida-Ushinomiya-cho, Sakyo-ku, Kyoto, 606-8501, Japan.
Faculty of Engineering/Graduate School of Engineering, Kyoto University of Advanced Science, Gotanda-cho, Yamanouchi, Ukyo-ku, Kyoto, 615-8577, Japan.

Ken-Ichiro Kamei (KI)

Institute for Integrated Cell-Material Sciences, Kyoto University, Yoshida-Ushinomiya-cho, Sakyo-ku, Kyoto, 606-8501, Japan. kamei.kenichiro.7r@kyoto-u.ac.jp.
Wuya College of Innovation, Shenyang Pharmaceutical University, 110016, Liaoning, China. kamei.kenichiro.7r@kyoto-u.ac.jp.
Department of Pharmaceutics, Shenyang Pharmaceutical University, 110016, Liaoning, China. kamei.kenichiro.7r@kyoto-u.ac.jp.
Programs of Biology and Bioengineering, Divisions of Science and Engineering, New York University Abu Dhabi, Abu Dhabi, UAE. kamei.kenichiro.7r@kyoto-u.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH